BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 14595750)

  • 21. O(6)-methylguanine methyltransferase in colorectal cancers: detection of mutations, loss of expression, and weak association with G:C>A:T transitions.
    Halford S; Rowan A; Sawyer E; Talbot I; Tomlinson I
    Gut; 2005 Jun; 54(6):797-802. PubMed ID: 15888787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low level microsatellite instability may be associated with reduced cancer specific survival in sporadic stage C colorectal carcinoma.
    Wright CM; Dent OF; Newland RC; Barker M; Chapuis PH; Bokey EL; Young JP; Leggett BA; Jass JR; Macdonald GA
    Gut; 2005 Jan; 54(1):103-8. PubMed ID: 15591513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence of microsatellite instability in synchronous tumors of the ovary and endometrium.
    Shannon C; Kirk J; Barnetson R; Evans J; Schnitzler M; Quinn M; Hacker N; Crandon A; Harnett P
    Clin Cancer Res; 2003 Apr; 9(4):1387-92. PubMed ID: 12684409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular screening of potential HNPCC patients using a multiplex microsatellite PCR system.
    Sutter C; Gebert J; Bischoff P; Herfarth C; von Knebel Doeberitz M
    Mol Cell Probes; 1999 Apr; 13(2):157-65. PubMed ID: 10208807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic alterations and MSI status in primary, synchronous, and metachronous tumors in a family with hereditary nonpolyposis colorectal cancer (HNPCC).
    González-Aguilera JJ; Nejda N; Fernández FJ; Medina V; González-Hermoso F; Barrios Y; Moreno Azcoita M; Fernández-Peralta AM
    Am J Clin Oncol; 2003 Aug; 26(4):386-91. PubMed ID: 12902892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of the National Cancer Institute international criteria for determination of microsatellite instability in ovarian cancer.
    Sood AK; Holmes R; Hendrix MJ; Buller RE
    Cancer Res; 2001 Jun; 61(11):4371-4. PubMed ID: 11389062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exon 3 beta-catenin mutations are specifically associated with colorectal carcinomas in hereditary non-polyposis colorectal cancer syndrome.
    Johnson V; Volikos E; Halford SE; Eftekhar Sadat ET; Popat S; Talbot I; Truninger K; Martin J; Jass J; Houlston R; Atkin W; Tomlinson IP; Silver AR
    Gut; 2005 Feb; 54(2):264-7. PubMed ID: 15647192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MSI-low, a real phenomenon which varies in frequency among cancer types.
    Halford SE; Sawyer EJ; Lambros MB; Gorman P; Macdonald ND; Talbot IC; Foulkes WD; Gillett CE; Barnes DM; Akslen LA; Lee K; Jacobs IJ; Hanby AM; Ganesan TS; Salvesen HB; Bodmer WF; Tomlinson IP; Roylance RR
    J Pathol; 2003 Nov; 201(3):389-94. PubMed ID: 14595750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microsatellite instability in colorectal cancer.
    Söreide K; Janssen EA; Söiland H; Körner H; Baak JP
    Br J Surg; 2006 Apr; 93(4):395-406. PubMed ID: 16555243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical and molecular consequences of microsatellite instability in human cancers].
    Hamelin R; Chalastanis A; Colas C; El Bchiri J; Mercier D; Schreurs AS; Simon V; Svrcek M; Zaanan A; Borie C; Buhard O; Capel E; Zouali H; Praz F; Muleris M; Fléjou JF; Duval A
    Bull Cancer; 2008 Jan; 95(1):121-32. PubMed ID: 18230578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathologic features in colorectal cancer patients with microsatellite instability.
    Raut CP; Pawlik TM; Rodriguez-Bigas MA
    Mutat Res; 2004 Dec; 568(2):275-82. PubMed ID: 15542114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does MSI-low exist?
    Tomlinson I; Halford S; Aaltonen L; Hawkins N; Ward R
    J Pathol; 2002 May; 197(1):6-13. PubMed ID: 12081205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microsatellite instability markers in breast cancer: a review and study showing MSI was not detected at 'BAT 25' and 'BAT 26' microsatellite markers in early-onset breast cancer.
    Siah SP; Quinn DM; Bennett GD; Casey G; Flower RL; Suthers G; Rudzki Z
    Breast Cancer Res Treat; 2000 Mar; 60(2):135-42. PubMed ID: 10845276
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.